| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6399101 | CEDIPROF INC | Stable thyroid hormone preparations and method of making same |
Mar, 2020
(4 years ago) | |
Levo-T is owned by Cediprof Inc.
Levo-T contains Levothyroxine Sodium.
Levo-T has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Levo-T are:
- US6399101
Levo-T was authorised for market use on 01 March, 2002.
Levo-T is available in tablet;oral dosage forms.
The generics of Levo-T are possible to be released after 30 March, 2020.
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 01 March, 2002
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
LEVO-T family patents
